AAS
RETA

Ameritas Advisory Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Ameritas Advisory Services’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,908
Closed -$355K – 2690
2023
Q1 		$355K Buy
+3,908
New +$355K 0.02% 593